ramipril

Generic: ramipril

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ramipril
Generic Name ramipril
Labeler rising pharma holdings, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

ramipril 5 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 57237-224
Product ID 57237-224_62ad78f6-6c57-4157-aae9-130ff95d57dd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091604
Listing Expiration 2026-12-31
Marketing Start 2011-06-08

Pharmacologic Class

Established (EPC)
angiotensin converting enzyme inhibitor [epc]
Mechanism of Action
angiotensin-converting enzyme inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 57237224
Hyphenated Format 57237-224

Supplemental Identifiers

RxCUI
198188 198189 261962 845488
UPC
0357237223017
UNII
L35JN3I7SJ
NUI
N0000175562 N0000000181

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ramipril (source: ndc)
Generic Name ramipril (source: ndc)
Application Number ANDA091604 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (57237-224-01)
  • 500 CAPSULE in 1 BOTTLE (57237-224-05)
source: ndc

Packages (2)

Ingredients (1)

ramipril (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "62ad78f6-6c57-4157-aae9-130ff95d57dd", "openfda": {"nui": ["N0000175562", "N0000000181"], "upc": ["0357237223017"], "unii": ["L35JN3I7SJ"], "rxcui": ["198188", "198189", "261962", "845488"], "spl_set_id": ["d5c58fb5-b415-4567-9790-55631705c5cd"], "pharm_class_epc": ["Angiotensin Converting Enzyme Inhibitor [EPC]"], "pharm_class_moa": ["Angiotensin-converting Enzyme Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (57237-224-01)", "package_ndc": "57237-224-01", "marketing_start_date": "20110608"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (57237-224-05)", "package_ndc": "57237-224-05", "marketing_start_date": "20110608"}], "brand_name": "Ramipril", "product_id": "57237-224_62ad78f6-6c57-4157-aae9-130ff95d57dd", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "57237-224", "generic_name": "Ramipril", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ramipril", "active_ingredients": [{"name": "RAMIPRIL", "strength": "5 mg/1"}], "application_number": "ANDA091604", "marketing_category": "ANDA", "marketing_start_date": "20110608", "listing_expiration_date": "20261231"}